RGS10 and ovarian cancer: Loss of RGS10 in these cells contributes to multiple phenotypes, such as overactive microglia-mediated neuroinflammation and subsequent neurodegeneration (18, 23, 94), cardiac hypertrophy (37), and ovarian cancer chemoresistance (40), respectively.